Patients who present with unique immunological phenotypes provide an opportunity to better understand defect-driving mutations. In this issue of the
Klaus Ley
The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.